Trillium Therapeutics (TRIL) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free TRIL Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSYRE Spyre Therapeutics, Inc.seekingalpha.com - April 11 at 8:22 PMViking Therapeutics Stock (NASDAQ:VKTX), Analyst Ratings, Price Targets, Predictionsbenzinga.com - February 22 at 7:07 AMBlue Cross & Blue Shield of Rhode Island Insurance Company Medicare Advantage Plans with Part Dhealth.usnews.com - February 21 at 2:44 AM2023-2030 Bromodomain Containing Protein 2 Market Size Detailed Report with Sales and Revenue Analysis | Research by Absolute Reportsmarketwatch.com - April 7 at 5:44 PMMonte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directorsfinance.yahoo.com - March 23 at 8:14 AMRatio Therapeutics Appoints Dr. Noel Monks as Head of Biologyfinance.yahoo.com - March 13 at 1:10 PMFactbox: Pfizer snaps up Seagen for $43 bln as drugmaker extends buying spreereuters.com - March 13 at 1:10 PMAllogene Therapeutics Stock (NASDAQ:ALLO), Quotes and News Summarybenzinga.com - February 24 at 11:21 PMTvardi Therapeutics Announces First Patients Dosed in Phase 2 Trial of TTI-101 in Metastatic Breast Cancerfinance.yahoo.com - February 23 at 4:13 PMViridian Therapeutics Names Scott Myers CEO, Succeeding Jonathan Violinmarkets.businessinsider.com - February 6 at 10:09 AMAlex Therapeutics presents results from digital therapeutic pilot study showing nearly 50% reduction in anxietyfinance.yahoo.com - October 26 at 9:03 PMPfizer in advanced talks to buy Global Blood Therapeutics for $5 billion - WSJfinance.yahoo.com - August 5 at 2:02 PMLeukemia Therapeutics Global Market Report 2022ca.finance.yahoo.com - July 29 at 7:48 AMTrillium Therapeutics Inc. Newsthestreet.com - July 18 at 6:16 PMRatio Therapeutics Launches to Discover and Drive Early Clinical Development of Best-in-Class Targeted Radiopharmaceuticals for Treatment of Cancersfinance.yahoo.com - June 10 at 2:40 PMPfizer Pays $11.6 Billion for Drug-Maker in Its Biggest Deal Since 2016chron.com - May 10 at 1:35 PMBloom Burton & Co. Inc.: Three Finalists Announced for the 2022 Bloom Burton Awardfinanznachrichten.de - May 10 at 8:34 AMThree Finalists Announced for the 2022 Bloom Burton Awardstockhouse.com - May 10 at 8:34 AMPfizer to buy migraine drugmaker Biohaven in $11.6-billion dealyahoo.com - May 10 at 8:34 AMGenScript ProBio Initiates a CDMO Contract For Next-Generation CD47 Antibody with InnoBation Biofinance.yahoo.com - January 26 at 7:14 PMCD47 Targeting Global Therapeutics Market 2021-2035, by Target Disease Indication, Type of Molecule Key Players and Key Geographical Regionsau.finance.yahoo.com - December 16 at 8:23 PMTrillium Therapeutics Receives Final Court Order Approving Arrangementfinance.yahoo.com - October 28 at 5:45 PMShareholders of cancer-drug developer Trillium Therapeutics approve takeover by Pfizer Inc.theglobeandmail.com - October 26 at 6:43 PMTrillium Securityholders Approve Acquisition by Pfizerfinance.yahoo.com - October 26 at 6:43 PMPfizer Gives Gov't More Time To Study $2.3B Trillium Deallaw360.com - October 13 at 5:49 PMIs Trillium Therapeutics Inc. (TSE:TRIL) Popular Amongst Institutions?finance.yahoo.com - October 5 at 12:54 PMHere's the Biotech Pfizer Should Consider Acquiring Nextmarkets.businessinsider.com - September 14 at 10:00 AMINVESTIGATION: Halper Sadeh LLP Investigates LMRK, HFC, NLOK, TRIL, LDL; Shareholders are Encouraged to Contact the Firmfinance.yahoo.com - August 26 at 4:03 PMSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Trillium Therapeutics Inc. (Nasdaq – TRIL)finance.yahoo.com - August 24 at 9:26 PMTRILLIUM THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Trillium ...businesswire.com - August 23 at 10:48 PMTrillium, Analog Devices rise: General Motors, Lennar fallmarketbeat.com - August 23 at 4:54 PMTop 5 Stock Gainers for Monday: Pfizer, Trillium, NextGen, Vivosthestreet.com - August 23 at 12:48 PMMid-Morning Market Update: Markets Open Higher; Pfizer To Acquire Trillium Therapeuticsmarkets.businessinsider.com - August 23 at 12:48 PMPfizer Beefs Up Blood Cancer Pipeline With Trillium Acquisition: See Highlightsfinance.yahoo.com - August 23 at 12:48 PMWhy Trillium Therapeutics Stock Is Skyrocketing Todayfinance.yahoo.com - August 23 at 12:48 PMPfizer to Acquire Cancer Drugmaker Trillium for $2.3 Billionfinance.yahoo.com - August 23 at 12:48 PMPfizer Agrees to Buy Cancer Biotech Trillium Therapeutics at a 200% Premiumfinance.yahoo.com - August 23 at 12:48 PMPfizer Nabs Cancer Deal For $2.26 Billion, Helping Trillium Stock Skyrocketfinance.yahoo.com - August 23 at 12:48 PMTropical Storm Henri’s mayhem, Boeing invests in Virgin Orbit, Pfizer’s newest acquisitionfinance.yahoo.com - August 23 at 12:48 PMTrillium Therapeutics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Trillium Therapeutics Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – TRILfinance.yahoo.com - August 23 at 12:48 PMPfizer to pay $2.26B for cancer treatment developer Trilliummarketbeat.com - August 23 at 9:49 AMTrillium: Q2 Earnings Snapshotchron.com - August 13 at 8:06 AMNorth American Morning Briefing: Investors Await -3-morningstar.com - August 11 at 7:00 AMTSX falls 0.06% to 20,097.52finance.yahoo.com - July 22 at 10:39 PM Get Trillium Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TRIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. TRIL Media Mentions By Week TRIL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TRIL News Sentiment▼0.000.45▲Average Medical News Sentiment TRIL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TRIL Articles This Week▼00▲TRIL Articles Average Week Get Trillium Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TRIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Tilray Brands News Cronos Group News dentalcorp News Canopy Growth News Sienna Senior Living News WELL Health Technologies News Neighbourly Pharmacy News Bausch Health Companies News Fennec Pharmaceuticals News Sernova News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:TRIL) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trillium Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
